Wells Fargo & Company Renovacor, Inc. Transaction History

Wells Fargo & Company

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.12 - $2.18 $1 - $19	9 Added 13.04%	78 $0
Q2 2022 Aug 12, 2022	BUY	$1.56 - $4.29 $7 - $21	5 Added 7.81%	69 $0
Q4 2021 Feb 14, 2022	BUY	$6.99 - $9.39 $447 - $600	64 New	64 $0

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.